Last reviewed · How we verify
Placebo medication + counseling
Placebo medication combined with counseling produces therapeutic benefit through psychological and behavioral mechanisms rather than pharmacological action.
Placebo medication combined with counseling produces therapeutic benefit through psychological and behavioral mechanisms rather than pharmacological action. Used for Psychological and behavioral conditions responsive to placebo and counseling (specific indication context-dependent).
At a glance
| Generic name | Placebo medication + counseling |
|---|---|
| Sponsor | University of Wisconsin, Madison |
| Modality | Small molecule |
| Therapeutic area | Psychiatry/Behavioral Health |
| Phase | FDA-approved |
Mechanism of action
This intervention leverages the placebo effect—the therapeutic benefit derived from patient expectation and the therapeutic relationship—combined with structured counseling to address psychological and behavioral factors. The counseling component provides evidence-based psychological support, while the placebo context enhances treatment engagement and perceived efficacy through expectation and therapeutic alliance.
Approved indications
- Psychological and behavioral conditions responsive to placebo and counseling (specific indication context-dependent)
Common side effects
- Minimal pharmacological adverse events expected
Key clinical trials
- Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1) (PHASE2, PHASE3)
- Exenatide for Smoking Cessation and Prevention of Weight Gain (PHASE2)
- The ENCHANTMENT HIV Study (PHASE2)
- LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response (PHASE1, PHASE2)
- Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction (PHASE2)
- Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression (NA)
- RECOVER-AUTONOMIC Platform Protocol (PHASE2)
- Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo medication + counseling CI brief — competitive landscape report
- Placebo medication + counseling updates RSS · CI watch RSS
- University of Wisconsin, Madison portfolio CI